{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:59:56Z","timestamp":1780502396404,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,24]]},"DOI":"10.7759\/cureus.30624","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T10:51:17Z","timestamp":1666608677000},"source":"Crossref","is-referenced-by-count":4,"title":["Cytarabine-Induced Bradycardia: A Case Report"],"prefix":"10.7759","author":[{"given":"Khalid","family":"Albsheer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Khalafalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Mustafa","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Al-Dubai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)91012-p","article-title":"Normal sinus heart rate: sinus tachycardia and sinus bradycardia redefined","volume":"4","author":"Spodick DH","year":"1992","unstructured":"Spodick DH. Normal sinus heart rate: sinus tachycardia and sinus bradycardia redefined. Am Heart J. 1992, 4:1119-21. 10.1016\/0002-8703(92)91012-p","journal-title":"Am Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(77)80094-5","article-title":"Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease","volume":"4","author":"Brodsky M","year":"1977","unstructured":"Brodsky M, Wu D, Denes P, Kanakis C, Rosen KM. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol. 1977, 4:390-5. 10.1016\/s0002-9149(77)80094-5","journal-title":"Am J Cardiol"},{"key":"ref3","article-title":"Sinus Bradycardia","author":"Hafeez Y","year":"2022","unstructured":"Hafeez Y, Grossman SA. Sinus Bradycardia. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800314","article-title":"Fluorouracil cardiotoxicity","volume":"28","author":"Anand AJ","year":"1994","unstructured":"Anand AJ. Fluorouracil cardiotoxicity. Ann Pharmacother. 1994, 28:374-8. 10.1177\/106002809402800314","journal-title":"Ann Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000227226","article-title":"Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study","volume":"50","author":"Akhtar SS","year":"1993","unstructured":"Akhtar SS, Salim KP, Bano ZA. Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study. Oncology. 1993, 50:441-4. 10.1159\/000227226","journal-title":"Oncology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini A","year":"2010","unstructured":"Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010, 102:14-25. 10.1093\/jnci\/djp440","journal-title":"J Natl Cancer Inst"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00056","article-title":"Review on the role of epigenetic modifications in doxorubicin-induced cardiotoxicity","volume":"7","author":"Kumari H","year":"2020","unstructured":"Kumari H, Huang WH, Chan MW. Review on the role of epigenetic modifications in doxorubicin-induced cardiotoxicity. Front Cardiovasc Med. 2020, 7:56. 10.3389\/fcvm.2020.00056","journal-title":"Front Cardiovasc Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1090","article-title":"Therapy insight: anthracyclines and trastuzumab\u2014the optimal management of cardiotoxic side effects","volume":"5","author":"Popat S","year":"2008","unstructured":"Popat S, Smith IE. Therapy insight: anthracyclines and trastuzumab\u2014the optimal management of cardiotoxic side effects. Nat Clin Pract Oncol. 2008, 5:324-35. 10.1038\/ncponc1090","journal-title":"Nat Clin Pract Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-009-0111-3","article-title":"QT interval prolongation among patients treated with angiogenesis inhibitors","volume":"4","author":"Ederhy S","year":"2009","unstructured":"Ederhy S, Cohen A, Dufaitre G, et al.. QT interval prolongation among patients treated with angiogenesis inhibitors. Target Oncol. 2009, 4:89-97. 10.1007\/s11523-009-0111-3","journal-title":"Target Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133187.74800.B9","article-title":"Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management","volume":"109","author":"Yeh ET","year":"2004","unstructured":"Yeh ET, Tong AT, Lenihan DJ, et al.. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004, 109:3122-31. 10.1161\/01.CIR.0000133187.74800.B9","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.01.013","article-title":"Cisplatin induced bradycardia","volume":"182","author":"Darling HS","year":"2015","unstructured":"Darling HS. Cisplatin induced bradycardia. Int J Cardiol. 2015, 182:304-6. 10.1016\/j.ijcard.2015.01.013","journal-title":"Int J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-604520","article-title":"An update of current treatments for adult acute myeloid leukemia","volume":"127","author":"Dombret H","year":"2016","unstructured":"Dombret H, Gardin C. An update of current treatments for adult acute myeloid leukemia. Blood. 2016, 127:53-61. 10.1182\/blood-2015-08-604520","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5152\/akd.2013.213","article-title":"High dose cytosin arabinoside induced sinus bradycardia in a Hodgkin's lymphoma patient. (Article in Turkish)","volume":"13","author":"Teke H\u00dc","year":"2013","unstructured":"Teke H\u00dc, Karag\u00fclle M, Akay OM. High dose cytosin arabinoside induced sinus bradycardia in a Hodgkin's lymphoma patient. (Article in Turkish). Anadolu Kardiyol Derg. 2013, 13:618-9. 10.5152\/akd.2013.213","journal-title":"Anadolu Kardiyol Derg"},{"key":"ref14","article-title":"High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22). (Article in Japanese)","volume":"44","author":"Kumagawa M","year":"2003","unstructured":"Kumagawa M, Suzuki K, Nagano M, Takamatsu Y, Suzumiya J, Tamura K. High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22). (Article in Japanese). Rinsho Ketsueki. 2003, 44:404-6.","journal-title":"Rinsho Ketsueki"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.00953.x","article-title":"Sinusal bradycardia after receiving intermediate or high dose cytarabine: four cases from a single institution","volume":"18","author":"Romani C","year":"2009","unstructured":"Romani C, Pettinau M, Murru R, Angelucci E. Sinusal bradycardia after receiving intermediate or high dose cytarabine: four cases from a single institution. Eur J Cancer Care (Engl). 2009, 18:320-1. 10.1111\/j.1365-2354.2008.00953.x","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/75038-cytarabine-induced-bradycardia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:54Z","timestamp":1707507774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/75038-cytarabine-induced-bradycardia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.30624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,24]]}}}